How Has the Albumin Market Evolved Historically and What is its Current Size?
The albumin market has seen considerable growth due to a variety of factors.
• The albumin market will expand from $6.57 billion in 2024 to $7.18 billion in 2025 at a CAGR of 9.3%.
This growth is driven by advancements in biotechnology, the increasing demand for plasma-derived therapies, expanding pharmaceutical applications, the high prevalence of liver diseases, regulatory approvals, and the globalization of healthcare.
What Does Future Hold for The Albumin Market in the Coming Years?
The albumin market is expected to maintain its strong growth trajectory in upcoming years.
• The albumin market is projected to grow to $10.16 billion by 2029, with a CAGR of 9.1%.
This growth is driven by the increasing prevalence of liver diseases, expanding applications in regenerative medicine, an aging population, improved diagnostic techniques, and a shift toward outpatient care. Trends include therapeutic applications expansion, adoption in drug delivery systems, cell culture media, personalized medicine, recombinant technology advancements, and increased R&D in albumin-based products.
What Factors Are Driving Growth In The Albumin Market?
The increasing incidence of diabetes is expected to fuel the growth of the albumin market. Diabetes prevalence is rising due to poor nutrition, lack of exercise, and obesity. Albumin is an important marker in diabetes management, helping guide insulin therapy and monitor complications. For instance, in January 2022, the National Library of Medicine reported that diabetes affected 10.5% of the global population in 2021, with projections suggesting an increase to 12.2% by 2045. This rise in diabetes cases is expected to drive the albumin market.
What Is The Segmentation Of The Global Albumin Market?
The albumin market covered in this report is segmented –
1) By Type: Human Serum Albumin, Bovine Serum Albumin, Recombinant Albumin
2) By Application: Therapeutics, Drug Formulation And Vaccines, Component Of Media, Other Applications
3) By Sales Channel: Business-To-Consumer (B2C), Business-To-Business (B2B)
4) By End-User: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Research Institutes
Subsegments:
1) By Human Serum Albumin: Plasma-Derived Human Serum Albumin, Recombinant Human Serum Albumin, Human Serum Albumin For Therapeutic Use (In Liver Disease, Burns), Human Serum Albumin For Drug Delivery And Research Applications
2) By Bovine Serum Albumin: Bovine Serum Albumin For Laboratory Use (In Cell Culture), Bovine Serum Albumin For Diagnostic Kits, Bovine Serum Albumin As A Stabilizer In Vaccines And Biopharmaceuticals
3) By Recombinant Albumin: Recombinant Human Albumin For Therapeutic Applications, Recombinant Albumin For Biopharmaceutical Formulation, Recombinant Albumin For Cosmetic And Personal Care Applications, Recombinant Albumin For Research And Diagnostic Applications
Pre-Book The Albumin Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Shaping The Albumin Market Landscape?
Companies in the albumin market are focusing on developing recombinant albumin products free from animal and human origins to provide advanced solutions. For example, in March 2023, Albumedix, a UK-based manufacturer, and Heartseed Inc., a Japan-based biotech company, partnered to launch Recombin, a recombinant albumin used in Heartseed's cell therapy, HS-001, which aims to treat various diseases and will be used in its first-in-human clinical trials.
Who Are the Key Players In The Albumin Market?
Major companies operating in the albumin market are:
• Bristol-Myers Squibb Company
• Thermo Fisher Scientific Inc.
• Takeda Pharmaceutical Company Limited
• Merck KGaA
• Baxter International Inc.
• CSL Limited
• Grifols SA
• Mitsubishi Tanabe Pharma Corporation
• Octapharma AG
• Kedrion S.p.A.
• Biotest AG
• Jiangxi Boya Bio-Pharmaceutical Co. Ltd.
• BPL (Bio Products Laboratory)
• Kamada Ltd.
• Proliant Biologicals
• SeraCare Life Sciences Inc.
• HiMedia Laboratories
• Albumedix Ltd.
• Medxbio Pte Ltd.
• Ventria Bioscience Inc.
• China Biologic Products Holdings Inc.
What Are The Regional Insights Into The Albumin Market?
North America was the largest region in the albumin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the albumin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
